LY3437943
LY3437943 is a pharmaceutical drug with 13 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
11
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
13 of 13 finished
0.0%
0 ended early
0
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943
A Study of LY3437943 in Participants With Impaired and Normal Liver Function
A Study of LY3437943 in Healthy Participants With a High Body Mass Index
A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices
Clinical Trials (13)
A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943
A Study of LY3437943 in Participants With Impaired and Normal Liver Function
A Study of LY3437943 in Healthy Participants With a High Body Mass Index
A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices
A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function
A Study of LY3437943 in Participants Who Have Obesity or Are Overweight
A Study of LY3437943 in Chinese Participants With Obesity Or Overweight
A Study of LY3437943 in Participants With Type 2 Diabetes
A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants
A Study of LY3437943 in Japanese Participants With Type 2 Diabetes Mellitus (T2DM)
A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)
A Safety Study of LY3437943 Given as a Single Injection in Healthy Participants
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13